- Home
- UPWK vs BEAM Comparison
UPWK vs BEAM Comparison
Compare UPWK & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPWK
- BEAM
- Stock Information
- Founded
- UPWK 2013
- BEAM 2017
- Country
- UPWK United States
- BEAM United States
- Employees
- UPWK N/A
- BEAM N/A
- Industry
- UPWK EDP Services
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UPWK Technology
- BEAM Health Care
- Exchange
- UPWK Nasdaq
- BEAM Nasdaq
- Market Cap
- UPWK 2.3B
- BEAM 2.3B
- IPO Year
- UPWK 2018
- BEAM 2020
- Fundamental
- Price
- UPWK $15.63
- BEAM $30.43
- Analyst Decision
- UPWK Strong Buy
- BEAM Buy
- Analyst Count
- UPWK 12
- BEAM 10
- Target Price
- UPWK $18.83
- BEAM $48.75
- AVG Volume (30 Days)
- UPWK 3.1M
- BEAM 1.2M
- Earning Date
- UPWK 02-12-2025
- BEAM 03-04-2025
- Dividend Yield
- UPWK N/A
- BEAM N/A
- EPS Growth
- UPWK 2286.76
- BEAM N/A
- EPS
- UPWK 1.52
- BEAM N/A
- Revenue
- UPWK $769,325,000.00
- BEAM $349,643,000.00
- Revenue This Year
- UPWK $2.09
- BEAM N/A
- Revenue Next Year
- UPWK $7.71
- BEAM $14.62
- P/E Ratio
- UPWK $10.39
- BEAM N/A
- Revenue Growth
- UPWK 11.64
- BEAM 328.73
- 52 Week Low
- UPWK $8.43
- BEAM $20.84
- 52 Week High
- UPWK $18.14
- BEAM $49.50
- Technical
- Relative Strength Index (RSI)
- UPWK 45.54
- BEAM 57.12
- Support Level
- UPWK $15.77
- BEAM $25.35
- Resistance Level
- UPWK $18.08
- BEAM $35.25
- Average True Range (ATR)
- UPWK 0.78
- BEAM 2.10
- MACD
- UPWK 0.07
- BEAM 0.56
- Stochastic Oscillator
- UPWK 26.43
- BEAM 55.88
About UPWK Upwork Inc.
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to clients.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.